Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Rituximab and leflunomide for Wegener's granulomatosis: a long-term follow-up.

Henes JC, Kanz L, Koetter I.

Rheumatol Int. 2011 Mar;31(3):425-6. doi: 10.1007/s00296-010-1462-x. Epub 2010 Mar 27. No abstract available.

PMID:
20349065
2.

[Severe Wegener's granulomatosis successfully treated with rituximab].

Semenkova EN, Krivosheev OG, Novikov PI, Osipenko VI, Nosova NR, Parfenova SA, Nikiforova NV, Borodin OO.

Ter Arkh. 2010;82(6):53-5. Russian.

PMID:
20731113
3.

Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.

Henes JC, Fritz J, Koch S, Klein R, Horger M, Risler T, Kanz L, Koetter I.

Clin Rheumatol. 2007 Oct;26(10):1711-5. Epub 2007 May 15.

PMID:
17502992
4.

Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.

de Menthon M, Cohen P, Pagnoux C, Buchler M, Sibilia J, Détrée F, Gayraud M, Khellaf M, Penalba C, Legallicier B, Mouthon L, Guillevin L.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S63-71. Epub 2011 May 11.

PMID:
21586199
5.

Maintenance of remission with leflunomide in Wegener's granulomatosis.

Metzler C, Fink C, Lamprecht P, Gross WL, Reinhold-Keller E.

Rheumatology (Oxford). 2004 Mar;43(3):315-20. Epub 2004 Jan 6.

6.

[Treatment of Wegener's granulomatosis].

Riccieri V, Valesini G.

Reumatismo. 2004 Apr-Jun;56(2):69-76. Review. Italian.

7.

Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades.

Holle JU, Gross WL, Latza U, Nölle B, Ambrosch P, Heller M, Fertmann R, Reinhold-Keller E.

Arthritis Rheum. 2011 Jan;63(1):257-66. doi: 10.1002/art.27763.

8.

Rituximab in refractory Wegener's granulomatosis: Favorable or not?

Aries PM, Lamprecht P, Gross WL.

Am J Respir Crit Care Med. 2006 Apr 1;173(7):815-6; author reply 816. No abstract available.

PMID:
16556703
9.

Successful treatment of gynaecological involvement of granulomatosis with polyangiitis (Wegener's granulomatosis) by rituximab.

Bastone P, Squifflet JL, Marbaix E, Houssiau F.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-142-4. Epub 2015 May 26.

PMID:
26016766
10.

Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.

Dalkilic E, Alkis N, Kamali S.

Mod Rheumatol. 2012 Jun;22(3):463-6. doi: 10.1007/s10165-011-0507-7. Epub 2011 Aug 17.

PMID:
21847703
11.

Reversible complete heart block due to Wegener's granulomatosis.

Wilcke JT, Nielsen PK, Jacobsen TN.

Int J Cardiol. 2003 Jun;89(2-3):297-8. No abstract available.

PMID:
12767556
12.

Refractory Wegener's granulomatosis: a model for shorter immunotherapy of autoimmune diseases.

Lockwood CM.

J R Coll Physicians Lond. 1998 Sep-Oct;32(5):473-8.

PMID:
9819743
13.

Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.

Ooka S, Maeda A, Ito H, Omata M, Yamada H, Ozaki S.

Mod Rheumatol. 2009;19(1):80-3. doi: 10.1007/s10165-008-0119-z. Epub 2008 Sep 18.

PMID:
18806927
14.

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

Mukhtyar C, Luqmani R.

Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv31-6. Review.

15.

Neurological involvement in Wegener's granulomatosis.

Holle JU, Gross WL.

Curr Opin Rheumatol. 2011 Jan;23(1):7-11. doi: 10.1097/BOR.0b013e32834115f9. Review.

PMID:
21124081
16.

Rituximab for refractory Wegener's granulomatosis.

Antoniu SA.

Expert Opin Investig Drugs. 2006 Sep;15(9):1115-7.

PMID:
16916277
17.

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.

Cartin-Ceba R, Fervenza FC, Specks U.

Curr Opin Rheumatol. 2012 Jan;24(1):15-23. doi: 10.1097/BOR.0b013e32834d5730. Review.

PMID:
22089095
18.

Leflunomide versus methotrexate in Wegener's granulomatosis.

Jayne D.

Rheumatology (Oxford). 2007 Jul;46(7):1047-8. Epub 2007 Apr 4. No abstract available.

19.

B cell strategy to maintain remission in ANCA-associated vasculitides?

Adler S, Villiger PM.

J Rheumatol. 2012 Jan;39(1):4-5. doi: 10.3899/jrheum.111313. No abstract available.

PMID:
22210675
20.

Refractory Wegener's meningitis treated with rituximab.

Bawa S, Mukhtyar C, Edmonds S, Webley M.

J Rheumatol. 2007 Apr;34(4):900-1. No abstract available.

PMID:
17407257
Items per page

Supplemental Content

Write to the Help Desk